Collectively, our data indicate that KO of CALM1 combined with EGFR inhibitor Afatinib displays synergistic effect in the suppression of metastasis of ESCC cells by suppressing the EMT process (Fig. 4g). Here, EGFR is linked to esophageal squamous cell carcinoma.